Neuroblastoma Research

Browse by Tags

• Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database.

  Related Articles Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group Database. J Clin Oncol. 2008 Dec 1; Authors: Bagatell R, Beck-Popovic... Posted Dec 03 2008, 08:04 AM by PubMed: neuroblastoma Filed under: J Clin Oncol

• The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report.

  Related Articles The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report. J Clin Oncol. 2008 Dec 1; Authors: Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern... Posted Dec 03 2008, 08:04 AM by PubMed: neuroblastoma Filed under: J Clin Oncol

• The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report.

  Related Articles The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report. J Clin Oncol. 2008 Dec 1; Authors: Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM, Faldum A, Hero B, Iehara T, Machin... Posted Dec 03 2008, 08:04 AM by PubMed: neuroblastoma Filed under: J Clin Oncol

• Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology Group.

  Related Articles Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem-Cell Rescue: A Report From the Children's Oncology... Posted Dec 03 2008, 08:04 AM by PubMed: neuroblastoma Filed under: J Clin Oncol

• PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma.

  Related Articles PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma. J Clin Oncol. 2008 Oct 6; Authors: Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold... Posted Oct 08 2008, 08:10 AM by PubMed: neuroblastoma Filed under: J Clin Oncol

• Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies.

  Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies. J Clin Oncol. 2008 Sep 20;26(27):4394-400 Authors: Geoerger B, Doz F, Gentet JC, Mayer M, Landman-Parker J, Pichon F, Chastagner P, Rubie H, Frappaz D, Le Bouil... Posted Sep 20 2008, 08:27 AM by PubMed: neuroblastoma Filed under: J Clin Oncol

• Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study.

  Related Articles Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Sep 15; Authors: Jakacki RI, Hamilton M,... Posted Sep 17 2008, 08:51 AM by PubMed: neuroblastoma Filed under: J Clin Oncol